A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05).

NCT05620576 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG: LY3857210
DRUG: Placebo

Sponsor

Eli Lilly and Company